Guidelines for Controlled Trials of Drugs in Migraine: Second Edition-Reference-Cited by-同舟云学术

Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

Published:2000-11 Issue:9 Volume:20 Page:765-786
ISSN:0333-1024
Container-title:Cephalalgia
language:en
Short-container-title:Cephalalgia

Author:

,Tfelt-Hansen P¹,Block G²,Dahlöf C³,Diener H-C⁴,Ferrari MD⁵,Goadsby PJ⁶,Guidetti V⁷,Jones B⁶,Lipton RB²,Massiou H⁸,Meinert C²,Sandrini G⁷,Steiner T⁶,Winter PBO⁶

Affiliation:

1. (Denmark)

2. (USA)

3. (Sweden)

4. (Germany)

5. (The Netherlands)

6. (United Kingdom)

7. (Italy)

8. (France)

Publisher

SAGE Publications

Subject

Clinical Neurology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.2000.00117.x

Reference106 articles.

1. Guidelines for Controlled Trials of Drugs in Migraine. First Edition

2. Guidelines for Trials of Drug Treatments in Tension-Type Headache

3. Methodology of Clinical Trials of Sumatriptan in Migraine and Cluster Headache

4. Sumatriptan

Cited by 479 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials;Headache: The Journal of Head and Face Pain;2024-06-22

2. Efficacy of cranial electrotherapy stimulation in patients with burning mouth syndrome: a randomized, controlled, double-blind pilot study;Frontiers in Neurology;2024-02-14

3. Variation in Endpoints in FDA Medication Approvals;Neurology;2023-09-05

4. Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications;Neurology;2023-09-05

5. Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension;Cephalalgia;2023-08